Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S298.
doi: 10.21037/atm.2019.11.07.

Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Daniele Focosi  1 , Marco Tuccori  2 , Fabrizio Maggi  3
Affiliations
Editorial

Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Daniele Focosi et al. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The PD-1/PD-L1 pathway in viral infections.
See this image and copyright information in PMC

Comment on

  • Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, Beck E, Reoma LB, Jacobson S, Reich DS, Nath A. Cortese I, et al. N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10. N Engl J Med. 2019. PMID: 30969503 Clinical Trial.

References

    1. Nambirajan A, Suri V, Kataria V, et al. Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine. Neurol India 2017;65:1061-4. 10.4103/neuroindia.NI_535_16 - DOI - PubMed
    1. Casado JL, Corral I, García J, et al. Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. Eur J Clin Microbiol Infect Dis 2014;33:179-87. 10.1007/s10096-013-1941-6 - DOI - PubMed
    1. Alstadhaug KB, Croughs T, Henriksen S, et al. Treatment of progressive multifocal leukoencephalopathy with interleukin 7. JAMA Neurol 2014;71:1030-5. 10.1001/jamaneurol.2014.825 - DOI - PubMed
    1. Focosi D, Tuccori M, Maggi F. Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: what do we know after 20 years of rituximab. Rev Med Virol 2019. [Epub ahead of print]. 10.1002/rmv.2077 - DOI - PubMed
    1. Carotenuto A, Scalia G, Ausiello F, et al. CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients. J Neuroimmunol 2017;309:47-50. 10.1016/j.jneuroim.2017.05.006 - DOI - PubMed